Clinical trial

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

NCT07166003

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-04-20

PhaseN/A

Study timeline

Study start (actual)2025-04-20Date precision: day

Registry last updated2025-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer, Non-Small Cellunresolved

Immunotherapyunresolved

Interventions

PneumonectomyPROCEDURE

lobectomyPROCEDURE

radiotherapyRADIATION

Anti-Tumor DrugsDRUG

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07166003 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.